5月20日盘中，京东健康（06618）股价大涨5.08%，引发市场关注。该公司近期发布的强劲财报数据以及多家机构的积极评级成为推动股价上涨的主要因素。
京东健康于近日公布的2025年第一季度财报显示，公司业绩大幅超出市场预期。期内实现收入166.45亿元，同比增长25.5%；经营盈利达10.71亿元，同比大幅增长119.8%。这一亮眼表现主要得益于药品和营养产品的强劲销售势头，以及公司毛利率的显著提升。
多家机构对京东健康的业绩表现给予积极评价。高盛将公司目标价由37.8港元上调至42.5港元，维持"买入"评级。高盛指出，京东健康在在线医疗健康行业的强大供应链能力和品牌知名度将助力其进一步扩大市场份额。此外，公司推出的"AI京医"产品体系也受到市场关注，体现了其在医疗科技创新方面的努力。值得注意的是，当日港股科技股普遍走强，也为京东健康股价提供了有利的市场环境。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.